Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

    ... graft-versus-host disease). Giving cyclosporine and mycophenolate mofetil before and after transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 1:52pm.

  2. Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease

    ... the body's normal cells. Giving cyclosporine and mycophenolate mofetil after transplant may stop this from happening. ...

    Clinical Trial last updated 04/29/2016 - 1:56pm.

  3. Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Sy

    ... body's normal cells. Giving cyclophosphamide together with mycophenolate mofetil and tacrolimus after the transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 1:01pm.

  4. Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

    ... irradiation, donor bone marrow transplant , mycophenolate mofetil, and tacrolimus in treating patients with hematologic cancer. Giving ...

    Clinical Trial last updated 04/29/2016 - 12:48pm.

  5. Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

    ... before the transplant together with cyclosporine and mycophenolate mofetil after the transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 1:11pm.

  6. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    ... Cyclophosphamide Mycophenolate Mofetil Phase:  ...

    Clinical Trial last updated 05/03/2016 - 11:43am.

  7. Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia

    ... Fludarabine Mycophenolate Mofetil Phase:  ...

    Clinical Trial last updated 04/29/2016 - 12:58pm.

  8. Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

    ... the body's normal cells. Giving cyclosporine and mycophenolate mofetil after the transplant may stop this from happening. ...

    Clinical Trial last updated 04/27/2016 - 1:27pm.

  9. A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

    ... (PO) with taper beginning on day 42. Patients also receive mycophenolate mofetil IV twice daily (BID) on days -1 to 28. After completion of study ...

    Clinical Trial last updated 04/27/2016 - 1:56pm.

  10. Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... (PO) beginning day -1 with a taper initiated on day 42 and mycophenolate mofetil IV twice daily (BID) on days -1 to 28 in the absence of GVHD. After ...

    Clinical Trial last updated 04/27/2016 - 1:37pm.